Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Stock Yards Bancorp
SYBT
$2.64B
| $332K | ﹤0.01% |
5,127
| – | – |
|
1927
IES Holdings
IESC
$14.8B
| $332K | ﹤0.01% |
9,333
+292
| +3% | +$9.47K |
|
1928
Hilltop Holdings
HTH
$2.26B
| $331K | ﹤0.01% |
+11,022
| New | +$314K |
|
1929
A.O. Smith
AOS
$8.29B
| $330K | ﹤0.01% |
5,772
-203,272
| -97% | -$11.4M |
|
|
VRTV
1930
DELISTED
VERITIV CORPORATION
VRTV
| $327K | ﹤0.01% |
+2,689
| New | +$326K |
|
1931
Edgewell Personal Care
EPC
$1.25B
| $327K | ﹤0.01% |
8,480
| – | – |
|
1932
Bloomin' Brands
BLMN
$741M
| $326K | ﹤0.01% |
16,181
-16,183
| -50% | -$351K |
|
1933
Verra Mobility
VRRM
$804M
| $325K | ﹤0.01% |
23,508
-23,510
| -50% | -$357K |
|
1934
Granite Construction
GVA
$5.29B
| $325K | ﹤0.01% |
9,276
+1
| +0% | +$33 |
|
1935
Trupanion
TRUP
$1.07B
| $325K | ﹤0.01% |
6,840
| – | – |
|
1936
Veracyte
VCYT
$3.7B
| $323K | ﹤0.01% |
13,633
-13,631
| -50% | -$317K |
|
1937
StoneX
SNEX
$9.26B
| $323K | ﹤0.01% |
17,182
| – | – |
|
1938
BancFirst
BANF
$3.79B
| $322K | ﹤0.01% |
3,651
| – | – |
|
1939
SiTime
SITM
$16B
| $321K | ﹤0.01% |
3,165
+1
| +0% | +$95 |
|
1940
Westamerica Bancorp
WABC
$1.38B
| $321K | ﹤0.01% |
5,440
+1
| +0% | +$59 |
|
|
EVOP
1941
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $319K | ﹤0.01% |
9,430
| – | – |
|
1942
Oxford Industries
OXM
$566M
| $319K | ﹤0.01% |
3,419
| – | – |
|
|
NEX
1943
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $318K | ﹤0.01% |
34,419
-34,419
| -50% | -$337K |
|
|
CVSA
1944
Covista Inc
CVSA
$4.25B
| $318K | ﹤0.01% |
8,960
| – | – |
|
1945
Vanguard Morningstar Growth ETF
VUG
$220B
| $316K | ﹤0.01% |
+8,910
| New | +$328K |
|
1946
ACM Research
ACMR
$5.42B
| $316K | ﹤0.01% |
40,996
-48,094
| -54% | -$408K |
|
1947
Ginkgo Bioworks
DNA
$528M
| $316K | ﹤0.01% |
4,656
-1,567
| -25% | -$144K |
|
1948
Tronox
TROX
$932M
| $315K | ﹤0.01% |
22,993
-22,995
| -50% | -$306K |
|
1949
Horace Mann Educators
HMN
$2.1B
| $314K | ﹤0.01% |
8,409
| – | – |
|
1950
Playtika
PLTK
$1.52B
| $314K | ﹤0.01% |
+36,909
| New | +$342K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.